Westwicke began working with biopharmaceutical company Kymera Therapeutics in April 2020, providing strategic advice for the company’s IPO, throughout the underwriter selection process, S-1 drafting process, and four-day virtual roadshow. In August 2020, Kymera priced its upsized IPO at $20 per share.
Download the case study to learn how Westwicke’s strategic advice led to a successful IPO, with shares closing up 66.3%.
Guidance is a key component of any investor relations program.
Download our checklist of do’s and don’ts for providing effective guidance to investors and analysts. Download Now
2800 Quarry Lake Drive, Suite 380
Baltimore, MD 21209 | (443) 213-0500 Directions
245 First Street, Riverview II, 18th Floor
Cambridge, MA 02142 | (339) 970-2843 Directions
761 Main Avenue
Norwalk, CT 06851 | (800) 210-2491 Directions
685 Third Avenue, 2nd Floor
New York, NY 10017 | (800) 210-2491 Directions
150 Spear Street, Suite 825
San Francisco, CA 94105 | (800) 210-2491 Directions
Unit 805, Tower 1, Prosper Center
No.5 Guanghua Road Chao Yang District
Beijing 100020, PR CHINA | (800) 210-2491 Directions